LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity

UDC.coleccionInvestigación
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicas
UDC.grupoInvInvestigación en Microbiología (INIBIC)
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruña
UDC.journalTitleFrontiers in Cellular and Infection Microbiology
UDC.startPage664169
UDC.volume15
dc.contributor.authorMoscoso, Miriam
dc.contributor.authorFuentes-Valverde, Víctor
dc.contributor.authorGarcía, Patricia
dc.contributor.authorVallejo, J. A.
dc.contributor.authorPérez-Ortega, Jesús
dc.contributor.authorSantamarina-Fernández, Rebeca
dc.contributor.authorCandela, Ana
dc.contributor.authorOviaño, Marina
dc.contributor.authorArenas, Jesús
dc.contributor.authorBou, Germán
dc.date.accessioned2025-11-10T08:43:54Z
dc.date.available2025-11-10T08:43:54Z
dc.date.issued2025-10-16
dc.description.abstract[Abstract] Introduction: Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen responsible for severe respiratory tract infections. We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. To reduce the toxicity of PAO1 ΔmurI without compromising its protective efficacy, we engineered strains with a modified lipid A structure, as lipid A is one of the main toxic components of whole-cell vaccines. Methods: Two lipid A-modifying enzymes, LpxR and PagL were overproduced in PAO1 ΔmurI derivatives. The resulting lipopolysaccharide (LPS) was analyzed by MALDI-TOF mass spectrometry. In vitro assays with HEK293-Blue reporter cells expressing murine and human Toll-like receptor 4 (TLR4) were used to assess LPS-associated toxicity, while in vivo reactogenicity and protective efficacy were evaluated in a murine acute pneumonia model. Results: LPS extracted from the wild-type strain showed heterogeneous lipid A structures with varying degrees of acylation, and a predominant penta-acylated species. Expression of LpxR led to enrichment in tetra-acylated species, while PagL expression reduced the heterogeneity observed in the wild type. Both mutant strains showed decreased TLR4 activation in vitro as compared to the wild type. In mice, lipid A-modified derivatives retained protective efficacy; however, no reduction in reactogenicity was observed. Discussion: Lipid A modifications mediated by LpxR and PagL attenuated TLR4 signaling in vitro but were insufficient to reduce in vivo reactogenicity. Additional modifications or targeting of other toxic components may be required. This strategy may serve as an initial basis for optimizing live attenuated P. aeruginosa vaccines, although additional approaches will likely be necessary to achieve substantial improvements.
dc.description.sponsorshipThis work was supported by a grant from the SERGAS-Galician Healthcare Service (Program “Innova Saúde”), CIBERINFEC, and the projects PI18/00501 and PI21/00704 to G.B., and the project PI20/00686 to M.O., integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 from the Ministry of Economy and Competitiveness and the Institute of Health Carlos III. In addition, this work was supported by the Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033 and, as appropriate, by ERDF A way of making Europe by the European Union or by the European Union Next Generation EU/PRTR (Grant agreement PID2020-114617RB-100) to J.A. V.F-V. was funded with a predoctoral fellowship from Conselleria de Cultura, Xunta de Galicia (IN606A-2019/012). A.C. was financially supported by the Río Hortega program (ISCIII-SERGAS, CM21/00165).
dc.identifier.citationMoscoso M, Fuentes-Valverde V, García P, Vallejo JA, Pérez-Ortega J, Santamarina-Fernández R, Candela A, Oviaño M, Arenas J, Bou G. LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity. Front Cell Infect Microbiol. 2025 Oct 16;15:1664169.
dc.identifier.doi10.3389/fcimb.2025.1664169
dc.identifier.issn2235-2988
dc.identifier.urihttps://hdl.handle.net/2183/46360
dc.language.isoeng
dc.publisherFrontiers
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI18%2F00501/ES/DISEÑO Y DESARROLLO DE UNA VACUNA PARA LA PREVENCION Y ERRADICACION DE LAS INFECCIONES RESPIRATORIAS AGUDAS Y CRONICAS (FIBROSIS QUISTICA) CAUSADAS POR PSEUDOMONAS AERUGINOSA/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00704/ES/VACUNAS AUXOTROFAS ORALES PARA LA ERRADICACION DE BACTERIAS INTESTINALES: COLONIZACIÓN INTESTINAL POR KLEBSIELLA PNEUMONIAE MULTIRRESISTENTE COMO MODELO/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00686/ES/DETECCION RAPIDA DE RESISTENCIAS ANTIBIOTICAS MEDIANTE ESPECTROMETRIA DE MASAS MALDI-TOF/
dc.relation.urihttps://doi.org/10.3389/fcimb.2025.1664169
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectD-glutamate auxotrophy
dc.subjectPseudomonas aeruginosa
dc.subjectHumoral immunity
dc.subjectLipid A modifying-enzymes
dc.subjectLipopolysaccharide
dc.subjectLive vaccines
dc.subjectProtective efficacy
dc.subjectReactogenicity
dc.titleLpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Moscoso_Lpxr_2025.pdf
Size:
5.05 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Moscoso_Lpxr_2025_Suppl.docx
Size:
671.99 KB
Format:
Microsoft Word XML
Description:
Supplementary material